Program Overview

MVP Health Care® (MVP) is excited to announce its 2024 Quality Incentive Program, offering eligible Participating Providers the opportunity to earn incentives by delivering high quality health care to MVP Members during calendar year 2024, and submitting appropriate coding. 

2024 Measures and Targets

  • Medicaid

    Measure/Link to MVP tip sheet

    Measure Description

    Incentive Target

    Payment per Compliant Gap Closed

    BCS-E

    Breast Cancer Screening - ECDS*

    5% improvement

    $25

    CHL

    Chlamydia Screening in Women

    5% improvement

    $25

    COL-E

    Colorectal Cancer Screening-ECDS

    5% improvement

    $25

    WCV*

    Child and Adolescent Well-Care Visits

    Gap closure in 2024 that was not a pass in 2023

    $25

    PPC

    Postpartum Care 

    5% improvement

    $25

    APM-E

    Metabolic Monitoring for Children and Adolescents on Antipsychotics-ECDS

    5% improvement

    $25

    SSD

    Diabetes Screening for People with Schizophrenia or bipolar disorder who are using Antipsychotic Medications

    5% improvement

    $25

    CBP

    Controlling High Blood Pressure

    5% improvement

    $25

  • Essential Plan

    Measure/Link to MVP tip sheet

    Measure Description

    Incentive Target

    Payment per Compliant Gap Closed

    BCS-E

    Breast Cancer Screening - ECDS*

    5% improvement

    $75

    CHL

    Chlamydia Screening in Women

    5% improvement

    $75

    EED

    Eye Exam for Patients with Diabetes

    5% improvement

    $75

    CBP

    Controlling High Blood Pressure

    5% improvement

    $75

    GSD

    Glycemic Status Assessment for patients with Diabetes

    5% improvement

    $75

  • HARP

    Measure/Link to MVP tip sheet

    Measure Description

    Incentive Target

    Payment per Compliant Gap Closed

    BCS-E

    Breast Cancer Screening - ECDS*

    5% improvement

    $75

    EED

    Eye Exam for Patients with Diabetes

    5% improvement

    $75

    CBP

    Controlling High Blood Pressure

    5% improvement

    $75

    GSD

    Glycemic Status Assessment for patients with Diabetes

    5% improvement

    $75

    SPC*

    Statin Therapy for Patients with Cardiovascular Disease

    Submission of relevant exclusion DX codes 

    $75

  • Medicare

    Measure/Link to MVP tip sheet

    Measure Description

    Incentive Target

    Payment per Compliant Gap Closed

    BCS-E

    Breast Cancer Screening - ECDS*

    5% improvement

    $75

    COL-E

    Colorectal Cancer Screening-ECDS

    5% improvement

    $75

    EED

    Eye Exam for Patients with Diabetes

    5% improvement

    $75

    CBP

    Controlling High Blood Pressure

    5% improvement

    $75

    GSD

    Glycemic Status Assessment for patients with Diabetes

    5% improvement

    $75

    SPC*

    Statin Therapy for Patients with Cardiovascular Disease

    Submission of relevant exclusion DX codes 

    $75

    SUPD*

    Statin Therapy for Patients with Diabetes

    Submission of relevant exclusion DX codes

    $75

Provider Eligibility Requirements 

Providers currently contracted in an existing value-based arrangement or quality incentive contract with MVP are ineligible for the QIP for those measures by LOB where currently contracted for. 

To confirm eligibility for the 2024 Quality Incentive Program please talk to your Provider Network Representative.

Program Requirements

For each incentivized measure by line of business, providers must achieve a minimum 5% rate improvement above 2023 Year End performance (admin) rate to be eligible for payment. Providers performing at 95% or above may also earn payment by achieving a rate of 98%, unless otherwise noted*. 

  • If the 5% minimum rate improvement for a measure is achieved, the provider is paid for all gaps closed for that measure in 2024
  • Providers below the 5% YOY improvement receive $0 payout for that measure

Upon completion of care, providers must submit the claim or supplemental data file containing all required codes to achieve performance improvement and receive payment.

* For the Child and Adolescent Well-Care Visits (WCV) incentive, payments are made per gap closed for members who receive care in 2024 and did not pass the measure in MY 2023. To be eligible for payment, the 2024 year end admin rate must be equal to or greater than the 2023 year end admin rate.

* For the Statin Therapy for Patients with CVD (SPC) and Statin Therapy for Patients with Diabetes (SUPD) incentives, payments are made to assess patients for intolerance to certain medications to support PDE exclusions and submit relevant exclusion DX codes

Measurement Period and Payment

Incentive payments will be made one time by the end of Q2 2025.

Payment is based on each eligible (attributed) patient who receives services, or claims we receive for services rendered for dates of service between January 1, 2024, and December 31, 2024. MVP must receive all claims by March 31, 2025. 

Quality Reports

Find quality reports at the practice site level in your Provider online account.